VaxForm specializes in the development of vaccine formulations. Our QYNDR oral delivery platform is revolutionizing mucosal vaccination. Press Releases: 24Sep2024 - VaxForm publishes manuscript in the journal Vaccines entitled "Formulation Attributes Impact Immune Profile of an Oral and Thermostable COVID-19 Subunit Vaccine" https://www.mdpi.com/2076-393X/12/10/1087/pdf
| Website | http://www.vaxform.com |
| Revenue | $202000 |
| Employees | 4 (3 on RocketReach) |
| Founded | 2010 |
| Address | 116 Research Drive, Bethlehem, Pennsylvania 18015, US |
| Phone | +1 610-573-9620 |
| Technologies |
HTML
,
Twitter
,
Polyfill
+5 more
(view full list)
|
| Industry | Biotechnology Research, Chemicals, Petrochemicals, Glass & Gases, Pharmaceuticals, Manufacturing, Other Healthcare Services |
| Web Rank | 25 Million |
| Keywords | Vaccine Technology, Vaccine Development, Next Generation Vaccines, Immunology, Drug Delivery, Vaccine Research, Pharmaceutical Research, Clinical Development, Biotechnology, Pharmaceutical Development, Therapeutics, Drug Discovery, Life Sciences, Healthcare |
| Competitors | United Road Towing, HealthPass, Evax Systems, HealthConnect (view competitors) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular VaxForm employee's phone or email?
The VaxForm annual revenue was $202000 in 2026.
Garry Morefield is the President of VaxForm.
3 people are employed at VaxForm.
VaxForm is based in Bethlehem, Pennsylvania.
The NAICS codes for VaxForm are [32, 325414, 3254, 32541, 325].
The SIC codes for VaxForm are [283, 28].